142 related articles for article (PubMed ID: 9164426)
1. Fluvoxamine in the treatment of compulsive buying.
Black DW; Monahan P; Gabel J
J Clin Psychiatry; 1997 Apr; 58(4):159-63. PubMed ID: 9164426
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder.
Black DW; Gabel J; Hansen J; Schlosser S
Ann Clin Psychiatry; 2000 Dec; 12(4):205-11. PubMed ID: 11140921
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying.
Ninan PT; McElroy SL; Kane CP; Knight BT; Casuto LS; Rose SE; Marsteller FA; Nemeroff CB
J Clin Psychopharmacol; 2000 Jun; 20(3):362-6. PubMed ID: 10831025
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
6. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
Reznik I; Sirota P
J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine treatment of obsessive-compulsive disorder.
Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
[TBL] [Abstract][Full Text] [Related]
8. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
9. The Yale-Brown Obsessive Compulsive Scale. II. Validity.
Goodman WK; Price LH; Rasmussen SA; Mazure C; Delgado P; Heninger GR; Charney DS
Arch Gen Psychiatry; 1989 Nov; 46(11):1012-6. PubMed ID: 2510699
[TBL] [Abstract][Full Text] [Related]
10. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253
[TBL] [Abstract][Full Text] [Related]
11. Hoarding in a compulsive buying sample.
Mueller A; Mueller U; Albert P; Mertens C; Silbermann A; Mitchell JE; de Zwaan M
Behav Res Ther; 2007 Nov; 45(11):2754-63. PubMed ID: 17868641
[TBL] [Abstract][Full Text] [Related]
12. L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.
Arabzadeh S; Shahhossenie M; Mesgarpour B; Rezaei F; Shalbafan MR; Ghiasi Z; Akhondzadeh S
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28485008
[TBL] [Abstract][Full Text] [Related]
13. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
Koran LM; Bromberg D; Hornfeldt CS; Shepski JC; Wang S; Hollander E
Compr Psychiatry; 2010; 51(4):373-9. PubMed ID: 20579510
[TBL] [Abstract][Full Text] [Related]
14. Compulsive buying severity: an analysis of Compulsive Buying Scale results in 44 subjects.
Black DW; Monahan P; Schlosser S; Repertinger S
J Nerv Ment Dis; 2001 Feb; 189(2):123-6. PubMed ID: 11225687
[No Abstract] [Full Text] [Related]
15. Compulsive buying and binge eating disorder--a case vignettes.
Marcinko D; Bolanca M; Rudan V
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1542-4. PubMed ID: 16815617
[TBL] [Abstract][Full Text] [Related]
16. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Mundo E; Guglielmo E; Bellodi L
Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
Bogetto F; Bellino S; Vaschetto P; Ziero S
Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.
van Balkom AJ; de Haan E; van Oppen P; Spinhoven P; Hoogduin KA; van Dyck R
J Nerv Ment Dis; 1998 Aug; 186(8):492-9. PubMed ID: 9717867
[TBL] [Abstract][Full Text] [Related]
19. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.
Neziroglu F; Yaryura-Tobias JA; Walz J; McKay D
J Child Adolesc Psychopharmacol; 2000; 10(4):295-306. PubMed ID: 11191690
[TBL] [Abstract][Full Text] [Related]
20. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Leckman JF; Holzer JC; Barr LC; McCance-Katz E; Heninger GR; Price LH
Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
